dg#13dd028cdf9bb664437670b08904d845

All Articles
Metabolites of Rg3 are Expected to Increase the Anti-cancer Properties of Rg3
dg#be7c0aa70f6cd3093219558fabe3586b
dg#7c4ed64e3058c2d73aab241a1f7c2f27

dg#b378c8b9ae30faf248d3f4886ad1c3d8

dg#43340e6cc4e88197d57f8d6d5ea50a46
Congratulation! BONTAC gains four more honors in health industry
dg#d5020e978dd01eb7d5fa1196c75d3065
dg#51ebb4484b9dc26e9ce53e7fe43fafef

dg#2884e81be7a28cb7b510fda05efb5b6c

dg#43340e6cc4e88197d57f8d6d5ea50a46
NR as a Driver of Macrophage Migration to Boost Chronic Wound Healing
dg#959dc1678cd4d5325a15d474a2e8dc00
dg#5a11929b847a7ff2ecbe3516513bbba1

dg#50ddead885ea1b570f2920acf07f332a

dg#43340e6cc4e88197d57f8d6d5ea50a46
An Integrated Map of Molecular Mechanisms Underlying the Effect of NMN in T2DM
dg#75009f75809bd3ac6cfd3cb6f3677f69
dg#33d6d0dc00e4eed7b7e92c07d11fa554

dg#3f5b395d4310d9b6e0ebf1fdc608a2a7

dg#43340e6cc4e88197d57f8d6d5ea50a46
BONTAC’s Patent-grade Coenzymes in 2024 CACLP&CISCE
dg#de11b7ac11d32508e2189d1b74ae1009
dg#1470f48302e185788d18ad00dc286c3f

dg#8093a27322cbfde3bd5d86be683779ec

dg#43340e6cc4e88197d57f8d6d5ea50a46
Unraveling Impacts of Ginsenoside Rg3 Treatment on IL-1β-induced Injury of NPCs
dg#de11b7ac11d32508e2189d1b74ae1009
dg#866a6a9087cbd7ce3b5c2e9239b33b3d

dg#111329f6391391b43ed933ca6cb0564c

dg#43340e6cc4e88197d57f8d6d5ea50a46
Application Value of Ginsenoside Rg3 in Targeting BCSCs to Treat Breast Cancer
dg#5e1fac01821814abefe261cdd885d4a8
dg#bf2ef50638e93f11e243df490791ae0a

dg#0f60f90c0bfe3a1fcc6ad6cc5634a2a7

dg#43340e6cc4e88197d57f8d6d5ea50a46
Fathoming Out the Role of NMN in Maintaining the Colon Health of Ageing Mice
dg#9e43d63ef219f47034f0d1afc4c8f5ba
dg#4a662a1a348525aef83c2d303c5d8eb8

dg#a55bbbf61cca117046bfed32b4165a29

dg#43340e6cc4e88197d57f8d6d5ea50a46
BONTAC is looking forward to your arrival at Booth No. 3A53 in 2024 PCHi
dg#183e0ff2c4ceb9e189eece8fcbe60204
dg#7af0b97f44735a05c0009b992308234f

dg#e5e0879baa02d5da66788eb7df92678b

dg#43340e6cc4e88197d57f8d6d5ea50a46
dg#a73c92b2ffb7ccf8c3914632ab8f889ddg#fe8a9f13cefc0336be0795f90685a0c4 dg#1fd72e016e8fbf2cf1f0c918dcd9bad3
dg#f3aead6a96f07f88672f94c9f07e4f16

dg#155851af4ef9fd531d184c1c82d2c6aa

[email protected]
dg#204c78292b5788bf5733b799f2a94df2
dg#c8c884a99c0290a67b7ef2577f7f6247

dg#f8ec0f3aa329ebfedf13a79184b7867e

dg#c46bb4038c89311e5754e5ed11371a92 dg#3e66a006b1ab752dde6343c0c3cc18fc dg#2be55d3f5a62bcd525832f90c7039645 dg#3843ee85091a4699b2174f345c9e9fe5 dg#9d97a1a1e4ba1ddcc80240d5a30e723f dg#f59a6c944fffc6eb66719bb0c371e574 dg#29473864686be8eb2f02635a88a0d5c5 dg#bf8fb81d13014620996dc79caf6921d9 dg#fab6162058e6c5917b47aef3449e95ab dg#616d6c054ea7a891fb9e625ec21a6171 dg#777c5ff55c5d5351eb8daf47c6c3e634 dg#00df21f2ccc25575daeb382c69377b1d dg#bb9a0f8ef367b89d911a3fd63bfc05fe dg#4cc4abae645601695e2120c62f39c368 dg#4c4668573d8921c7207bdcced53be078 dg#063db98a47c3686d420f67d3933ebe5d dg#cb897aea75c14f031f26d730a2cbddb7 dg#e52072d02b17b449d516bd03d79afb75 dg#d13ec7e42cf4fca0af546bfcb8edad01 dg#865b0248d4213454293808332031db8c dg#889467e18352fcb6d4a3341d9446346e dg#f8650c460e3e7659321861ff31eaa744 dg#5c7159475c88bcb5514ef59dc7215cb4 dg#6078834fb8b5a0ba09faed504c13a94b dg#76723645363ece6d63a79b43cf7d1924 dg#47d3f09ee37182d4aaf5c829756d0190 dg#2a7d74300bdac0585b8cdb05ba3054c5 dg#d3e23a5adc2b467e3df7b30a9d94aa94 dg#003782dd1bb4ac78eeb21bacaae7ae06 dg#3ffc6d9fb0b86e8ef2c4c9cc4fbe8168